International News

Australian farmers in Tasmania increase hemp seed production for food

The number of hemp producers in the Australian state of Tasmania, which produces 66% of the nation’s commercial hemp crop, has nearly doubled – and is projected to continue growing due to drought causing supply shortage in other regions, according to Australia’s ABC News. Tasmania has produced hemp for fiber and cosmetics since the 1990s, but […]

Read More

GW Pharma denies supply issues with cannabis-based drug Epidiolex after stock falls

GW Pharmaceuticals, the British maker of epileptic seizure-control medication Epidiolex, said it was not aware of any supply issues related to the cannabis-derived drug after a tweet from a patient’s father complained he could not source the medicine. GW’s stock was down more than 3% on Wednesday on the Nasdaq after the tweet from San […]

Read More

FSD Pharma reveals hemp purchase agreement after Auxly deal collapses

Ontario-based FSD Pharma has agreed to buy 1,000 kilograms (2,200 pounds) of hemp on a contractual basis from a farmer in the province for CBD extraction at the company’s Cobourg facility. The move comes after the breakdown last week of an agreement between FSD and marijuana company Auxly for the purchase of 49.9% of the […]

Read More

Uruguay continues Latin American cannabis leadership with hemp industry

Uruguay, often recognized as the pioneer in legalized recreational marijuana, is also building a solid foundation to support its hemp industry. “Uruguay is an agricultural country with a clear regulatory framework that offers attractive conditions for large-scale outdoor cultivation (of hemp),” said Maria Belen Algorta, who oversees Uruguay operations for Australia-based Ecofibre. “As far as […]

Read More

CBD boom goes bust in Austria as officials ban the extract in food, cosmetics

Austria’s Minister of Health ordered businesses to immediately stop selling CBD food and cosmetics because the products fall under the European Union’s definition of “novel food.” Cannabidiol is explicitly included in the EU’s novel food catalog, which means individual member countries may limit the marketing and sale of it without specific authorization. Business Association Cannabis Austria CEO Stefan Wolyniec […]

Read More

Canada cannabis giant ups stake in Italian CBD manufacturer

A subsidiary of Canadian cannabis giant Canopy Growth is increasing its investment in an Italian hemp company. Canopy Rivers announced that it will spend 17.4 million Canadian dollars ($13 million) to increase its ownership in CanapaR Corp., the parent company of CanapaR SrL, a hemp-derived CBD manufacturer based in Sicily. The deal gives Canopy Rivers 49.9% […]

Read More

New Zealand legalizes hempseed as food, issues guidelines

A regulatory change in New Zealand has opened the doors to hemp as food in the island nation. “Hemp seeds are safe to eat and nutritious,” Bryan Wilson, head of New Zealand Food Safety, said in the announcement about the changes that now allow the sale of hempseed foods. The new guidance is being embraced by […]

Read More

Canadian cannabis company adds Polish hemp grower to European portfolio

A Canadian cannabis company has bought a Polish hemp firm to expand CBD production in Europe. ICC International Cannabis Corp. announced Tuesday that it has acquired Polannabis Holdings, which includes a company that grows 850 acres of hemp and has licenses to extract CBD. ICC is paying 2.5 million Canadian dollars ($1.9 million) and 26.5 […]

Read More

Polish petroleum firm inks deal to produce biofuel from hemp

A government-owned petroleum firm in Poland has struck a deal to produce bioethanol from hemp. Grupa Lotos, one of the 10 largest fuel companies in Central Europe by sales, entered the agreement with the state-owned Institute of Natural Fibers and Medicinal Plants, Hemp Today reported. The Institute grows and researches natural fibers such as hemp […]

Read More

GW Pharmaceuticals poised to raise $300 million in stock offering

Cannabis biopharmaceutical company  GW Pharmaceuticals is setting out to sell $300 million worth of U.S. depository shares. The London-based company’s announcement comes on the heels of the U.S. Drug Enforcement Administration’s move to take some cannabidiol products off the most restrictive class of controlled substances. That change will allow Epidiolex – a CBD drug manufactured by GW Pharmaceuticals […]

Read More